Fund Evaluator:
iShares Global Healthcare ETF (IXJ)
Follow This Fund
Equity
Global Asset Class
Sector Equity
Fund Group
Health
Category
$60.720
NAV (as of Oct 07)
$0.00
Minimum Initial
0.38% B
Expense Ratio
$4,093 Mil
Assets
Open
Status
na
12b-1 Fee
1.44%
TTM Yield
0.00%
Max Load
2%
Portfolio Turnover
Best Performing in Health Over the Last Year
| 62.8% | Fidelity Advisor Biotechnology Z (FIJYX) |
| 62.6% | Fidelity Advisor Biotechnology I (FBTIX) |
| 56.2% | Eventide Healthcare & Life Sciences N (ETNHX) |
| 53.5% | Fidelity Select Biotechnology (FBIOX) |
| 49.5% | Fidelity Select Pharmaceuticals Port (FPHAX) |
Data as of 7/31/2026
1.9% B
1-Mo Return
8.8% D
3-Mo Return
3.9% D
YTD Return
22.5% D
1-Yr Return
6.8% D
3-Yr Return
4.6% B
5-Yr Return
0.66 A
Category Risk Index
1.09
Total Risk Index
Fund Details
Fund Family
iShares
Inception Date
11/13/2001
Share Class Type
Equity Investment Style
Large-Cap
Value
Bond Investment Style
na
Socially Responsible Fund
No
Index Fund
Yes
Benchmark Index
S&P Global BMI TR USD: 100%
Additional Fund Details
iShares Global Healthcare ETF Overview
IXJ Trailing NAV Total Returns Data as of 7/31/26
| Last Month |
Last Quarter |
Ann'l. 1Yr |
Ann'l. 3Yr |
Ann'l. 5Yr |
Ann'l. 10Yr |
|
| IXJ Return (NAV) | 1.9% | 8.8% | 22.5% | 6.8% | 4.6% | 8.2% |
| IXJ Grade | B | D | D | D | B | D |
| +/- Category | 2.3% | -1.9% | -11.4% | -3.9% | -0.4% | -1.1% |
| Health Avg | -0.4% | 10.7% | 33.9% | 10.7% | 5.0% | 9.3% |
| IXJ Tax Cost Ratio | na | na | 0.5% | 0.4% | 0.4% | 0.4% |
IXJ Annual NAV Total ReturnsData as of 7/31/26
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| IXJ Return (NAV) | 3.9% | 14.9% | 0.6% | 3.5% | -4.7% | 19.5% | 12.5% | 23.4% | 2.9% | 20.3% | -6.2% |
| IXJ Grade | D | D | C | B | B | B | F | C | B | D | C |
| +/- Category | -3.2% | -5.8% | -1.9% | -2.1% | 4.7% | 10.8% | -12.0% | -5.0% | 2.5% | -3.1% | 4.7% |
| Health Avg | 7.1% | 20.6% | 2.5% | 5.6% | -9.4% | 8.7% | 24.5% | 28.4% | 0.4% | 23.4% | -10.9% |
| Risk Measures | |
| Standard Deviation: | 13.4% |
| Total Risk Index: | 1.09 - Average |
| Category Risk Index: | 0.66 - Low |
| Category Risk Grade: | A (4% Rank) |
| Beta: | 0.52 |
| R-Squared: | 24% |
| Leveraged Fund: | No |
| Inverse Fund: | No |
| Portfolio Characteristics | |
| Equity Investment Style: | Large-Cap Value |
| Bond Investment Style: | na |
| Yield: | 1.4% |
| Dividend Distribution: | Semi-Annually |
| Cap Gains Distribution: | Annually |
| Total Assets: | $4093 Mil |
| Fund Total Assets: | $4,093 Mil |
| Share Class Type: | |
| Portfolio Turnover: | 2% |
Management Team
| Number of Managers: 4 | |||
| Longest Tenure: 14.0 years | |||
| Average Tenure: 4.5 years | |||
| Managers (Year): Hsui Jennifer (2012), Sietsema Peter (2025), Waldron Matt (2025), White Steven (2025) | |||
Portfolio Composition (as of 7/31/26)
| # of Holdings: | 125 |
| % in Top 10 Holdings: | 47.0% |
| Fund is Non-Diversified: | No |
| % in Foreign Issues: | 27.1% |
Portfolio Allocation |
|
| Domestic Stock: | 72.6% |
| Foreign Stock: | 27.1% |
| Preferred Stock: | 0.0% |
| Domestic Bond: | 0.0% |
| Foreign Bond: | 0.0% |
| Convertible Bond: | 0.0% |
| Other: | 0.0% |
| Cash: | 0.4% |
Purchase Information
| Fund Family: | iShares |
| Phone Number: | 800-474-2737 |
| Website: | au.ishares.com |
| Status: | Open |
| Inception Date: | November 13, 2001 |
| Min. Initial Purchase: | $ 0 |
| Min. Initial IRA Purchase: | $ 0 |
| True No-Load: | Yes |
| Front Load Maximum: | 0.00% |
| Deferred Charge Maximum: | 0.00% |
| Redemption Charge Maximum: | 0.00% |
| 12b-1 Fee: | na |
Expenses and Fees | |
| Expense Ratio (%): | 0.38% ( Rating : Below Avg ) |
| Category Average Expense Ratio (%): | 1.21% |
| Share Class: | iShares Global Healthcare ETF |
| Min. Subsequent Purchase: | $ 0 |
| Min. Subsequent IRA Purchase: | $ 0 |
Copyright 2026 American Association of Individual Investors and Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.